By Chris Wack Cellectar Biosciences shares were up 10% to $2.91 on Monday after the company said it secured four patents across Europe, Australia and Canada,.
Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.